» Authors » Seiichi Hirota

Seiichi Hirota

Explore the profile of Seiichi Hirota including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 357
Citations 3468
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamada Y, Taguchi M, Shimatani K, Yanagi T, Kanematsu A, Kako Y, et al.
Int J Urol . 2025 Feb; PMID: 39912123
Objective: To assess the usefulness of transarterial embolization (TAE) before a transurethral resection of bladder tumor (TURBT) procedure for large bladder tumors, intra- and postoperative outcomes were retrospectively compared between...
2.
Nagahashi M, Ishikawa E, Nagai T, Kanaoka H, Oshiro A, Togashi Y, et al.
Breast Cancer . 2025 Jan; 32(2):404-415. PMID: 39808396
Purpose: The aim of this study was to examine the clinical utility of tumor-infiltrating lymphocytes (TILs) evaluated by "average" and "hot-spot" methods in breast cancer patients. Methods: We examined 367...
3.
Hamada K, Nakanishi Y, Muta Y, Omatsu M, Iwane K, Ikeda M, et al.
Cell Mol Gastroenterol Hepatol . 2024 Dec; 19(3):101435. PMID: 39631567
Background & Aims: Retinoblastoma-binding protein 9 (RBBP9) was initially reported as cell cycle regulator via RB/E2F. Accumulating evidence has revealed the importance of RBBP9 in physiological and pathological states including...
4.
Oguro-Igashira E, Murakami M, Mori R, Kuwahara R, Kihara T, Kohara M, et al.
Proc Natl Acad Sci U S A . 2024 Oct; 121(44):e2318767121. PMID: 39432783
The intestinal lumen is rich in gut microbial metabolites that serve as signaling molecules for gut immune cells. G-protein-coupled receptors (GPCRs) sense metabolites and can act as key mediators that...
5.
Ishikawa E, Watanabe T, Kihara T, Kuroiwa M, Komatsu M, Urano S, et al.
Breast Cancer Res Treat . 2024 Oct; 209(2):291-302. PMID: 39402242
Purpose: Tumor-infiltrating lymphocyte (TIL) levels are prognostic and predictive factors for breast cancer. Unlike other subtypes, most luminal A breast cancers are immune deserts; however, the underlying mechanisms are poorly...
6.
7.
Yoshida M, Yuan J, Kihara T, Kimura N, Yamasaki T, Ohkouchi M, et al.
Exp Mol Pathol . 2024 Aug; 139:104922. PMID: 39096891
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the alimentary tract. The prognosis depends on the primary site, and small intestinal GISTs have a worse prognosis than...
8.
Hirota S, Tateishi U, Nakamoto Y, Yamamoto H, Sakurai S, Kikuchi H, et al.
Int J Clin Oncol . 2024 Apr; 29(6):647-680. PMID: 38609732
The Japan Society of Clinical Oncology Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) have been published in accordance with the Minds Manual for Guideline Development 2014 and 2017....
9.
10.
Okano H, Nakatsuka A, Ogura M, Mukai K, Nishimura A, Asakawa K, et al.
Cureus . 2024 Feb; 16(1):e52394. PMID: 38361680
A 49-year-old man with abdominal pain was referred to our hospital. Abdominal computed tomography showed an extraluminal tumor near the gastric anterior wall and intra-abdominal fluid collection. A ruptured intra-abdominal...